Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06788717 · ClinicalTrials.gov registry record

MDR - Comprehensive Primary Revision Stems PMCF

A clinical trial of Shoulder Pain and Shoulder Injuries, sponsored by Zimmer Biomet.

Recruiting
Registry status
59
Enrollment target
2
Study locations

NCT06788717 is a study of Shoulder Pain and Shoulder Injuries that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 59 participants, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06788717, a study of Shoulder Pain and Shoulder Injuries, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
59 participants
Enrollment target
2
Study locations

Study Summary

The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.

Interventions

  • DEVICE Comprehensive Primary Revision Stems

Study Locations (2)

California

  • Cedars Sinai Medical Center - Los Angeles

Other

  • Aalborg University Hospital - Aalborg

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2025-06-19
Est. Completion 2040-12

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT06788717

The ClinicalTrials.gov registry entry for NCT06788717 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (40% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Primary Revision Stems is the first listed.

NCT06788717 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.

Frequently Asked Questions

What is clinical trial NCT06788717 about?

NCT06788717 is a clinical study titled "MDR - Comprehensive Primary Revision Stems PMCF". The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthr...

What is the current status of trial NCT06788717?

This trial is currently recruiting. The enrollment target is 59 participants. The study started on 2025-06-19. Estimated completion is 2040-12.

What conditions does trial NCT06788717 study?

This clinical trial studies the following conditions: Shoulder Pain, Shoulder Injuries, Shoulder Arthritis, Shoulder Disease, Shoulder Fractures.

What interventions are being tested in trial NCT06788717?

The interventions under investigation include: Comprehensive Primary Revision Stems (DEVICE).

Who is sponsoring clinical trial NCT06788717?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06788717 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.